First Patient Enrolled in Merit Medical’s MOTION Study

January 17, 2024

https://www.globenewswire.com/news-release/2024/01/16/2810316/8028/en/First-Patient-Enrolled-in-Merit-Medical-s-MOTION-Study.html

SOUTH JORDAN, Utah, Jan. 16, 2024 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading global manufacturer and marketer of healthcare technology, today announced the successful enrollment of the first patient in its multicenter, prospective, randomized, controlled trial comparing genicular artery embolization (GAE) using Embosphere® Microspheres to corticosteroid injections for the treatment of symptomatic knee osteoarthritis (MOTION) study.

Read more at globenewswire.com

Related news for (MMSI)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.